ARK Innovation ETF (ARKK) Next Earnings Date & Expected ±6.2% Move

Per the Roarable RQD rating, ARKK scores 55 out of 100, graded D+, with the verdict label "Roarable Sell — Weak Fundamentals / Trim (ETF Composite Methodology)." The five pillars are: Fundamental Cash Engine at 17/20 (ROIC 0%; FCF yield 0%); Whale 13F Flow at 9/20 (institutional accumulation and options positioning); Insider Conviction at 7/20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit at 9/20 (Beta 1.0; sector sensitivity); and Forensic Balance Sheet at 13/20 (Altman Z 2.5; Piotroski F 6/9; Debt/Equity 0.5).

For a prospective investor, the scoring indicates that the composite is weighed down by weak cash-generation metrics as reported in the market data, with ROIC and FCF yield both at 0%, and by modest insider conviction. The balance sheet pillar is the relative strength, with a Piotroski F-Score of 6 out of 9 and an Altman Z of 2.5. Because ARKK is an ETF, the fundamental metrics applied to operating companies do not map directly onto the fund's holdings, so the Cash Engine reading should be interpreted as the rating methodology's output rather than a direct measure of underlying company economics. Beta of 1.0 indicates the fund moves in line with the broader market in the source data, so the Macro Regime pillar reflects sensitivity rather than a distinct directional call. Upside drivers would be a rebound in the underlying holdings' cash generation and renewed institutional accumulation; the valuation tradeoff is that no P/E or EV/EBITDA is available in source data to anchor price against earnings.

ARK Innovation ETF is an exchange-traded fund classified in the ETF / Index sector and the Disruptive Growth & Biotech industry, listed on the NYSE. Per the profile, it is described as a liquid institutional fund tracking Disruptive Growth & Biotech with approximately $6.5B in assets under management. The source data does not describe its holdings composition, fee structure, or investor base beyond what is stated here.

Per the recent news feed, five items reference ARKK. The headlines describe a quarterly portfolio update showing total Ark Invest portfolio growth to $15.4 Billion, with Tesla, AMD, and a new SpaceX stake together making up about 18% of ARKK assets; a Q3 review of biggest winners and losers including PLTR, NVDA, and TXG as leaders and TSLA and RKLB as drags; a report of $5M in bullish share additions across three ETFs (flagged CATALYST, green); reporting on purchases in air taxi and defense names; and reporting on sales of PLTR, GOOG, and SHOP alongside purchases of PACB, FRNM, and other biotech firms. Watch items are the concentration of holdings noted in the headlines and the rotation between sectors described across the feed. The Butterfly Supply-Chain Graph reports no supply chain and no links or proprietary signals, so no graph-derived signal is available.

Per the Butterfly Supply-Chain Graph, the supply chain is reported as NONE, with an empty list of butterfly links and no proprietary signals. The source data therefore does not establish upstream or downstream dependencies for ARKK. Sector correlations and second-order bottlenecks cannot be derived from the provided sources. The news feed references individual holdings (such as Tesla, AMD, NVDA, PLTR, and biotech names), and any ripple effects from those names would depend on information not contained in these sources.

• What are ARKK's actual holdings, weights, and expense ratio, given that the source data references concentrated positions but does not list them?
• What is the fund's net asset value and recent flow history, since AUM is given only as an approximate $6.5B?
• How does the Roarable pillar methodology translate fund-level data into the ROIC and FCF yield figures reported as 0%?
• What are the reported income and cash flow figures for the largest underlying holdings?
• What is the basis for the 1.3% dividend yield, and how often is it distributed?